News

A powerful new ally is emerging in cancer care: artificial intelligence (AI). In the ever-evolving landscape of prostate ...
Education and patient advocacy are essential to improving care in Waldenström macroglobulinemia amid clinical advances, ...
A phase 1b study of HC-7366 plus Welireg for advanced clear cell renal cell carcinoma has completed the dose escalation ...
Connecting with nature through journaling, walking and meditation helped me heal during and after colon cancer treatment.
The first patient has received treatment with mavrostobart plus chemo in the phase 1/2 MORNINGSTAR trial for advanced solid ...
A variant in the IL-7 gene may predict which patients with kidney cancer are more likely to experience side effects from immunotherapy.
Dr. Tiziano Barbui explains how excess blood cell production in certain myeloproliferative neoplasms can impair circulation and why treatments like phlebotomy are used.
Dr. Andrew M. Evens discusses long-term survivorship challenges that can occur among adolescent and young lymphoma survivors.
After being diagnosed with breast cancer at 39, I learned to advocate for myself, transforming fear into fierce resolve and ...
I reflect on my journey from caregiver to advocate, embracing a future shaped by cancer but no longer defined by it.
Maria, my oncology nurse, inspired lasting change in my life through compassion, wisdom and faith during my cancer surgery ...
Proton therapy may reduce urinary, bowel and sexual side effects in prostate cancer by minimizing radiation exposure to ...